Related Experiment Video
Updated: Aug 8, 2026

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 2, 2013
Human urinary bladder carcinomas express adenovirus attachment and internalization receptors
A Loskog1, T Hedlund, K Wester
1Clinical Immunology Division, Rudbeck Laboratory, University of Uppsala, Uppsala, Sweden.
Gene Therapy
|April 26, 2002
Summary
Adenoviral vectors require the Coxsackievirus/adenovirus receptor (CVADR) for gene delivery. Bladder cancer biopsies show abundant CVADR, supporting adenoviral vector use in gene therapy for bladder cancer.
Area of Science:
- Oncology
- Virology
- Gene Therapy
Background:
- Adenoviral vectors are potent gene delivery systems.
- Effective gene delivery requires Coxsackievirus/adenovirus receptor (CVADR) and integrins on target cells.
- Previous reports indicated potential loss of CVADR in bladder cancer cell lines.
Purpose of the Study:
- To investigate the expression of CVADR and specific integrins in bladder carcinoma biopsies.
- To assess the suitability of adenoviral vectors for gene therapy in bladder cancer.
Main Methods:
- Immunohistochemistry was used to analyze surgical biopsies and bladder cancer cell lines for CVADR, integrins alpha(v)beta(3) and alpha(v)beta(5), and MHC class I expression.
- Transduction efficiency of adenoviral vectors in cell lines was evaluated.
- The effect of anti-CVADR antibodies on transduction was studied.
Main Results:
- All analyzed bladder cancer biopsies (27/27) expressed CVADR, with higher expression in superficial tumors compared to invasive ones.
- Integrin alpha(v)beta(5) was expressed in most tumors (14/24), while alpha(v)beta(3) was less common (3/20).
- Established bladder cancer cell lines demonstrated efficient transduction with adenoviral vectors, which was inhibitable by anti-CVADR antibodies.
Conclusions:
- The consistent expression of CVADR in bladder cancer biopsies supports the use of adenoviral vectors for gene therapy.
- The presence of necessary viral receptors on tumor cells is a key factor for successful adenoviral vector-mediated gene delivery in bladder cancer.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Adherens Junctions
Strong contact points between adjacent cells anchor them to each other, forming tissues. Such anchoring junctions are of two types – adherens junctions and desmosomes. Adherens junctions are abundant in tissues such as epithelium and endothelium, forming a continuous zone of adhesion called the adhesion belt. In other tissues, such as heart muscle, they appear as clusters, linking the cells to produce coordinated heart muscle contraction.
Adherens Junctions are Dynamic
The endothelial cells...
Adherens Junctions are Dynamic
The endothelial cells...

